+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point-of-Care Diagnostics Market in US - Industry Outlook and Forecast 2019-2024

  • ID: 4749338
  • Report
  • Region: United States
  • 183 pages
  • Arizton
UP TO OFF
until Nov 30th 2019
1 of 4

FEATURED COMPANIES

  • Abaxis
  • AgaMatrix
  • BD
  • Danaher
  • Exact Sciences
  • LifeScan
  • MORE
The US point-of-care diagnostics market is expected to generate revenues of around $11 billion by 2024, growing at a CAGR of more than 7% during 2018-2024.

The emergence of wearable medical devices, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices in the US market. The growing availability of rapid tests for diagnosing infectious diseases like HIV, TB or malaria, that enable physicians and patients to visualize the results from a smartphone and take appropriate clinical decisions will transform the market over the next few years. The US point-of-care diagnostics market is driven by the latest innovations in diagnostics industry is to provide an expedited diagnosis for quick clinical decision making to support treatment regimens.

The growing need to deliver quantitative lab-quality results and transfer to an information system, or a healthcare professional, or store as an electronic medical record for future analysis and interpretation will drive the demand for new technologies in the US point-of-care diagnostics market. The market research report provides in-depth market analysis and segmental analysis of the US point-of-care diagnostics market by product, technology, usage type, and end-users.

The report considers the present scenario of the US point-of-care diagnostics market and its market dynamics for the period 2019-2024. It covers a detailed overview of various market growth enablers, restraints, and trends. The report segments the market based on the product type (POC analyzers and consumables); application type (blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing); usage type (professional POC diagnostics and at-home POC diagnostics) and end-user type (professional healthcare settings, home care, and others), while elaborating the present market scenario and discussing the futuristic demand in the market for POC diagnostics.

It also profiles and analyzes the leading companies and various other prominent companies operating in the market. The report also discusses the future market growth, improvement areas, and strategic recommendations for the US point-of-care diagnostics market vendors.

Point-of-Care Diagnostics Market in US - Dynamics

The leading vendors are increasingly focusing on technological advancements and improvement is one of the major factors contributing to the growth of the US POC diagnostic market. The leading companies are leveraging technology for the development of highly advanced and innovative POC analyzers and rapid test kits in the US market. A broad range of acute and chronic diseases is encouraging players to develop advanced technological platforms, analyzers, test kits, and reagents in the market.

The development of real-time PCR (qPCR)expanded the role of molecular diagnostics in the healthcare industry. The molecular diagnostic tests performed at POC setting or near the patients are resulting in breakthrough tests in recent years in the US market. Molecular testing can improve the specificity and sensitivity of existing near-patient and rapid diagnostic tests, thereby propelling the growth of the US POC diagnostic market.

The increasing application of this diagnostic testing across laboratory settings will boost the demand in the market. The growing requirement for the early and accurate diagnosis of a specific ailment that results in effective treatment will lead to the demand in the US POC diagnostic market. With POC testing immediate decision making in cases of sepsis or stroke, quick, and precise confirmation of clinical findings is becoming easier in the market. xPOCT is known as a simultaneous on-site measurement of different analytes from a single sample, and it is gaining immense popularity in the USPOC diagnostic market.

Point-of-Care Diagnostics Market in US - Segmentation

This market research report includes a detailed segmentation of the market by product, technology, usage type, and end-users. The US point-of-care diagnostics market by product is segmented into POC analyzers and consumables. Consumables segment dominated more than half of the total market share in 2018, growing at a CAGR of approximately 8% during the forecast period. The increasing use of various rapid tests across emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing various diseases is propelling the growth of this segment in the US market. The POC analyzers market is growing at a higher growth rate than clinical laboratory analyzers market as end-users are preferring analyzers which deliver immediate results with less turnaround time.

Diagnostic tests with POC analyzers have the capability to deliver results in hours and to make quick decision making for treating a disease. Therefore, increase in target population with various diseases is encouraging many end-users to procure compact and advanced POC analyzers for performing various diagnostic tests.

The application segment in the US point-of-care diagnostics market is classified into blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing. Infectious disease testing is the fastest growing technology segment in the US market, at a CAGR of around 11% during the forecast period. The launch of POC diagnostics and rapid test kits providing accurate and quick diagnostics is propelling the growth of this segment in the US market. The growing prevalence of diabetes in the US and increasing demand for self-monitoring of blood glucose are the major factors contributing to this segment’s growth. Around 10% of people have some form of diabetes in the country.

The US point-of-care diagnostics market by end-user is categorized into professional healthcare settings, home care, and others. The professional healthcare segment occupied more than half of the total market share in 2018, growing at a CAGR of around 7% during the forecast period. The increasing use of point-of-care diagnostics technology for detecting of acute and chronic diseases is fueling the growth of this segment in the US market.

The increasing use of self-monitoring devices and test kits as an early symptom management tool and to manage high-risk chronically ill patients will drive the growth of the home care segment in the US market. The usage segment in the US point-of-care diagnostics market is divided into professional POC diagnostics and at-home POC diagnostics. At-home POC diagnostic is the fastest growing segment in the US market, at a CAGR of more than 7% during the forecast period. The cost-effective and quick results of this procedure are augmenting the growth of this segment in the US market. The increasing launch of many innovative and compact POC analyzers and the rapid test will contribute to the growing revenues in the US point-of-care diagnostics market.

Market Segmentation by Product
  • POC Analyzers
  • Consumables
Market Segmentation by Application
  • Blood Glucose Testing
  • Cardiovascular and Metabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drugs of Abuse Testing
  • Pregnancy and Fertility/Ovulation Testing
Market Segmentation by Usage
  • Professional POC Diagnostics
  • At-Home POC Diagnostics
Market Segmentation by End-users
  • Professional Healthcare Settings
  • Home Care
  • Others
Key Vendor Analysis

The US point-of-care diagnostics market is highly dynamic due to the presence of several international and regional players operating in the region. The vendors are offering a diverse range of analyzers and kits to attract the maximum number of consumers in the US market. Strategical partnerships and consolidation will positively impact the development of the competitive landscape in the US. Effective strategies such as the expansion of product offerings, accessing new technology, and increasing market share will help companies survive the intense competition in the US point-of-care diagnostics market.

The major vendors in the US market are:
  • Abbott
  • F. Hoffmann-La Roche
  • Siemens Healthineers
Key companies to watch are:
  • Danaher
  • LifeScan
  • Ascensia Diabetes Care Holdings
  • Quidel
  • BD
Other prominent vendors include: Abaxis, AgaMatrix, Arbor Vita, bioMérieux, Chembio Diagnostic Systems EKF Diagnostics USA, Exact Sciences, Instrumentation Laboratory, Meridian Bioscience, Sekisui Diagnostics, Sinocare, Sysmex America, Swiss Precision Diagnostics and Trinity Biotech.

Key market insights include:

1. The analysis of US point-of-care diagnostics market provides market size and growth rate for the forecast period 2019-2024.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the US point-of-care diagnostics market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of US point-of-care diagnostics market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and key market strategies to gain competitive advantage.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis
  • AgaMatrix
  • BD
  • Danaher
  • Exact Sciences
  • LifeScan
  • MORE
1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Product Types
4.3.2 Market Segmentation by Application Types
4.3.3 Market Segmentation by Usage
4.3.4 Market Segmentation by End-user Types

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Inclusions
5.3 Exclusions
5.4 Currency Conversion
5.5 Market Derivation

6 Market at a Glance

7 Introduction
7.1 POC: An Overview

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increase in Prevalence/Incidence of Several Acute and Chronic Diseases
8.1.2 New Product Approvals/Launches
8.1.3 Increasing Number of CLIA Waiver POC Tests
8.1.4 High Focus on Early Diagnosis and Disease Prevention
8.1.5 Vendors’ Focus on Manufacturing Innovative POC Platforms for Existing and New Applications
8.1.6 YOY Impact of Market Growth Enablers
8.2 Market Growth Restraints
8.2.1 Time Consuming and Stringent Regulations for Approvals of POC Diagnostics
8.2.2 Limitations and Data Accuracy Challenges with POC Diagnostics
8.2.3 YOY Impact of Market Growth Restraints
8.3 Market Opportunities & Trends
8.3.1 Growing Demand for POC Molecular Diagnostic Testing
8.3.2 High Growth Potential for Multiplexed POC Diagnostic Testing (xPOCT)
8.3.3 Strategic Acquisitions
8.3.4 Robust Pipeline and Investigational POC Diagnostic Devices
8.3.5 Development of Microfluidic-based POC devices
8.3.6 YOY Impact of Market Opportunities & Trends

9 Point-of-care Diagnostics Market in US
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Porter’s Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry

10 By Product
10.1 Market Overview
10.2 Consumables
10.2.1 Market Overview
10.2.2 Market Size & Forecast
10.3 POC Analyzers/Instruments
10.3.1 Market Overview
10.3.2 Market Size & Forecast

11 By Application
11.1 Market Overview
11.2 Blood Glucose Testing
11.2.1 Market Overview
11.2.2 Market Size & Forecast
11.3 Cardiovascular and Metabolic Testing
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Infectious Disease Testing
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 POC Blood Coagulation Testing
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 POC Hematology Testing
11.6.1 Market Size & Forecast
11.7 POC Cancer Testing
11.7.1 Market Overview
11.7.2 Market Size & Forecast
11.8 POC Drugs of Abuse Testing
11.8.1 Market Size & Forecast
11.9 Pregnancy and Fertility/Ovulation Testing
11.9.1 Market Size & Forecast

12 By End-user
12.1 Market Overview
12.2 Professional Healthcare Settings
12.2.1 Market Overview
12.2.2 Professional Healthcare Settings: Market Size & Forecast
12.2.3 Hospitals and Laboratories: Market Size & Forecast
12.2.4 Ambulatory Care Settings: Market Size & Forecast
12.2.5 Emergency Care/Urgent Care Centers: Market Size & Forecast
12.3 Home Care
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Other End-users
12.4.1 Market Size & Forecast

13 By Prescription
13.1 Market Overview
13.2 Professional POC Diagnostics
13.2.1 Market Size & Forecast
13.3 At-home/OTC-based POC
13.3.1 Market Size & Forecast

14 Competitive Landscape
14.1 Market overview
14.2 Market Vendor Share/Ranking Analysis

15 Key Company Profiles
15.1 Abbott
15.1.1 Business Overview
15.1.2 Abbott in Point-of-care Diagnostics Market in US
15.1.3 Major Product Offerings
15.1.4 Key Strategies
15.1.5 Key Strengths
15.1.6 Key Opportunities
15.2 F. Hoffmann-La Roche
15.2.1 Business Overview
15.2.2 F. Hoffmann-La Roche in Point-of-care Diagnostics Market in US
15.2.3 Major Product Offerings
15.2.4 Key Strategies
15.2.5 Key Strengths
15.2.6 Key Opportunities
15.3 Siemens Healthineers
15.3.1 Business Overview
15.3.2 Siemens Healthineers in Point-of-care Diagnostics Market in US
15.3.3 Major Product Offerings
15.3.4 Key Strategies
15.3.5 Key Strengths
15.3.6 Key Opportunities

16 Key Companies to Watch
16.1 Danaher
16.1.1 Business Overview
16.1.2 Danaher in Point-of-care Diagnostics Market in US
16.1.3 Product Offerings
16.1.4 Key Strategies
16.1.5 Key Strengths
16.1.6 Key Opportunities
16.2 LifeScan
16.2.1 Business Overview
16.2.2 Product Offerings
16.2.3 Key Strategies
16.2.4 Key Strengths
16.2.5 Key Opportunities
16.3 Ascensia Diabetes Care Holdings
16.3.1 Business Overview
16.3.2 Product Offerings
16.3.3 Key Strategies
16.3.4 Key Strengths
16.3.5 Key Opportunities
16.4 BD
16.4.1 Business Overview
16.4.2 BD in Point-of-care Diagnostics Market in US
16.4.3 Product Offerings
16.4.4 Key Strategies
16.4.5 Key Strengths
16.4.6 Key Opportunities
16.5 Quidel
16.5.1 Business Overview
16.5.2 Quidel in Point-of-care Diagnostics Market in US
16.5.3 Product Offerings
16.5.4 Key Strategies
16.5.5 Key Strengths
16.5.6 Key Opportunities

17 Other Prominent Vendors
17.1 Abaxis
17.1.1 Business Overview
17.1.2 Product Offerings
17.2 ACON Laboratories
17.2.1 Business Overview
17.2.2 Product Offerings
17.3 AgaMatrix
17.3.1 Business Overview
17.3.2 Product Offerings
17.4 Arbor Vita
17.4.1 Business Overview
17.4.2 Product Offerings
17.5 bioMérieux
17.5.1 Business Overview
17.5.2 Product Offerings
17.6 Chembio Diagnostic Systems
17.6.1 Business Overview
17.6.2 Product Offerings
17.7 EKF Diagnostics USA (Stanbio Laboratory)
17.7.1 Business Overview
17.7.2 Product Offerings
17.8 Exact Sciences
17.8.1 Business Overview
17.8.2 Product Offerings
17.9 Instrumentation Laboratory
17.9.1 Business Overview
17.9.2 Product Offerings
17.10 Meridian Bioscience
17.10.1 Business Overview
17.10.2 Product Offerings
17.11 Sekisui Diagnostics
17.11.1 Business Overview
17.11.2 Product Offerings
17.12 Sinocare
17.12.1 Business Overview
17.12.2 Product Offerings
17.13 Sysmex America
17.13.1 Business Overview
17.13.2 Product Offerings
17.14 Swiss Precision Diagnostics
17.14.1 Business Overview
17.14.2 Product Offerings
17.15 Trinity Biotech
17.15.1 Business Overview
17.15.2 Product Offerings

18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations
18.3 Qualitative Summary
18.4 Quantitative Summary
18.4.1 Market by Application
18.4.2 Market by Product
18.4.3 Market by Usage Type
18.4.4 Market by End-users

19 Appendix
19.1 Abbreviations

List of Exhibits
Exhibit 1 Segmentation of Point-of-care Diagnostics Market in US
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Diagnosis Steps Involved in Non-waived and CLIA-waived Diagnostic Testing
Exhibit 4 Advantages of Early Diagnosis and Prevention
Exhibit 5 Major POC Diagnostic Testing Limitations
Exhibit 6 Common Errors in POC Diagnostic Tests
Exhibit 7 Point-of-care Diagnostics Market in US 2018-2024 ($ million)
Exhibit 8 Five Forces Analysis 2017
Exhibit 9 Point-of-care Diagnostics Market in US by Product Type
Exhibit 10 Point-of-care Diagnostics Market in US 2018 and 2024 (%)
Exhibit 11 Point-of-care Diagnostics Market in US 2018-2024 ($ million)
Exhibit 12 Point-of-care Diagnostics Market in US by POC Test Kits/Consumables 2018-2024 ($ million)
Exhibit 13 Point-of-care Diagnostics Market in US by Analyzers/Instruments 2018-2024
Exhibit 14 Point-of-care Diagnostics Market in US by Application Type
Exhibit 15 Point-of-care Diagnostics Market in US by Application 2018 and 2024 (%)
Exhibit 16 Point-of-care Diagnostics Market in US by Application 2018-2024 ($ million)
Exhibit 17 Point-of-care Diagnostics Market in US by Blood Glucose Testing 2018-2024 ($ million)
Exhibit 18 Point-of-care Diagnostics Market in US by Cardiometabolic Testing 2018-2024 ($ million)
Exhibit 19 Point-of-care Diagnostics Market in US by Infectious Disease Testing 2018-2024 ($ million)
Exhibit 20 Point-of-care Diagnostics Market in US by Blood Coagulation Testing 2018-2024 ($ million)
Exhibit 21 Point-of-care Diagnostics Market in US by Hematology 2018-2024 ($ million)
Exhibit 22 Point-of-care Diagnostics Market in US by Cancer Testing 2018-2024 ($ million)
Exhibit 23 Point-of-care Diagnostics Market in US by Drugs of Abuse Testing 2018-2024 ($ million)
Exhibit 24 Point-of-care Diagnostics Market in US by Pregnancy and Fertility/Ovulation Testing 2018-2024 ($ million)
Exhibit 25 Point-of-care Diagnostics Market in US by End-user
Exhibit 26 Point-of-care Diagnostics Market in US 2018 and 2024 (%)
Exhibit 27 Point-of-care Diagnostics Market in US by End-user 2018-2024 ($ million)
Exhibit 28 Point-of-care Diagnostics Market in US by Professional Healthcare Settings 2018 (%)
Exhibit 29 Point-of-care Diagnostics Market in US by Professional Healthcare Settings 2018-2024 ($ million)
Exhibit 30 Point-of-care Diagnostics Market in US by Professional Healthcare Settings 2018-2024 (%)
Exhibit 31 Point-of-care Diagnostics Market in US by Professional Healthcare Settings 2018-2024 ($ million)
Exhibit 32 Point-of-care Diagnostics Market in US by Hospitals and Laboratories 2018-2024 ($ million)
Exhibit 33 Point-of-care Diagnostics Market in US by Ambulatory Care Settings 2018-2024 ($ million)
Exhibit 34 Point-of-care Diagnostics Market in US by Emergency Care/Urgent Care Centers 2018-2024 ($ million)
Exhibit 35 Point-of-care Diagnostics Market in US by Home Care 2018-2024 ($ million)
Exhibit 36 Point-of-care Diagnostics Market in US by Other End-users 2018-2024 ($ million)
Exhibit 37 Point-of-care Diagnostics Market in US by Usage Type
Exhibit 38 Point-of-care Diagnostics Market in US by Usage Type 2018 & 2024 (%)
Exhibit 39 Point-of-care Diagnostics Market in US by Usage Type 2018-2024 ($ million)
Exhibit 40 Point-of-care Diagnostics Market in US by Usage Type 2018-2024 (%)
Exhibit 41 Prescription-based Point-of-care Diagnostics Market in US 2018-2024 ($ million)
Exhibit 42 At-home/OTC-based Point-of-care Diagnostics Market in US 2018-2024 ($ million)
Exhibit 43 Abbott Sales Breakdown by Segments 2017
Exhibit 44 F. Hoffmann-La Roche Sales Breakdown by Divisions 2017
Exhibit 45 Siemens Healthineers Revenue Breakdown by Business Segments 2017 (%)
Exhibit 46 Danaher Sales Breakdown by Business Segments 2017 (%)
Exhibit 47 Danaher Business Segments R&D Expenditure 2017 (%)
Exhibit 48 Quidel Revenue Breakdown by Product Categories 2017 (%)

List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013-2017
Table 3 Recent Product Approvals in Point-of-care Diagnostics Market in US
Table 4 Tests Granted CLIA-waived Status by CMS and their CPT Codes Recently
Table 5 Few Popular Innovative POC Diagnostics Available in US
Table 6 YOY Impact of Market Growth Enablers 2018-2024
Table 7 YOY Impact of Market Growth Restraints 2018-2024
Table 8 Popular POC Molecular Diagnostics and Tests in US
Table 9 xPOCT Systems Available in US
Table 10 Recent Acquisitions in Point-of-care Diagnostics Market
Table 11 Point-of-care Diagnostics Market in US: Pipeline Devices and Tests
Table 12 Microfluidic-based POC Devices Under Investigation
Table 13 YOY Impact of Market Opportunities & Trends 2018-2024
Table 14 Popular Blood Glucose Meter Brands in US
Table 15 Point-of-care Diagnostics Market in US: Vendors Ranking
Table 16 Abbott: Product Offerings
Table 17 F. Hoffmann-La Roche: Product Offerings
Table 18 Siemens Healthineers: Product Offerings
Table 19 Danaher: Product Offerings
Table 20 LifeScan: Product Offerings
Table 21 Ascensia Diabetes Care: Product Offerings
Table 22 BD: Product Offerings
Table 23 Quidel: Product Offerings
Table 24 Abaxis: Product Offerings
Table 25 ACON Laboratories: Product Offerings
Table 26 AgaMatrix: Product Offerings
Table 27 Arbor Vita: Product Offerings
Table 28 bioMérieux: Product Offerings
Table 29 Chembio Diagnostic Systems: Product Offerings
Table 30 EKF Diagnostics: Product Offering
Table 31 Exact Sciences: Product Offerings
Table 32 Instrumentation Laboratory: Major Product Offerings
Table 33 Meridian Bioscience: Product Offerings
Table 34 Sekisui Diagnostics: Product Offerings
Table 35 Sinocare: Product Offerings
Table 36 Sysmex America: Product Offerings
Table 37 Swiss Precision Diagnostics: Product Offerings
Table 38 Trinity Biotech: Product Offerings
Table 39 Qualitative Summary of Point-of-care Diagnostics Market in US
Table 40 Point-of-care Diagnostics Market in US by Application 2018-2024
Table 41 Point-of-care Diagnostics Market in US by Product Types 2018-2024
Table 42 Point-of-care Diagnostics Market in US by Prescription Types 2018-2024
Table 43 Point-of-care Diagnostics Market in US by End-user 2018-2024
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Chembio Diagnostic Systems
  • Ascensia Diabetes Care Holdings
  • Arbor Vita
  • Swiss Precision Diagnostics
  • Sysmex America
  • Sinocare
  • Sekisui Diagnostics
  • Meridian Bioscience
  • Instrumentation Laboratory
  • Exact Sciences
  • EKF Diagnostics USA
  • Quidel
  • BioMérieux
  • Abaxis
  • Abbott
  • BD
  • AgaMatrix
  • F.Hoffmann-La Roche
  • LifeScan
  • Siemens Healthineers
  • Danaher
Note: Product cover images may vary from those shown
Adroll
adroll